ATHENEX INC FDA Approval ANDA 076770

ANDA 076770

ATHENEX INC

FDA Drug Application

Application #076770

Documents

Letter2004-04-29
Other Important Information from FDA2011-02-17

Application Sponsors

ANDA 076770ATHENEX INC

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION1MG/ML0TERBUTALINE SULFATETERBUTALINE SULFATE

FDA Submissions

ORIG1AP2004-04-23
LABELING; LabelingSUPPL6AP2011-04-08

Submissions Property Types

SUPPL6Null7

TE Codes

001PrescriptionAP

CDER Filings

ATHENEX INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 76770
            [companyName] => ATHENEX INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"TERBUTALINE SULFATE","activeIngredients":"TERBUTALINE SULFATE","strength":"1MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"TERBUTALINE SULFATE","submission":"TERBUTALINE SULFATE","actionType":"1MG\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.